검체 회수 시스템 시장 : 시장 예측(2026-2032년)

The Specimen Retrieval Systems Market is projected to grow by USD 572.69 million at a CAGR of 5.90% by 2032.

Specimen Retrieval Systems: Executive Overview

Specimen retrieval systems are essential devices used in minimally invasive surgery to contain and remove excised tissue, organs, calculi, and other surgical specimens while reducing the risk of contamination, port-site seeding, fluid leakage, and specimen fragmentation. Their adoption is closely tied to the global shift toward laparoscopic, robotic-assisted, endoscopic, gynecologic, urologic, bariatric, colorectal, and general surgery procedures, where controlled extraction through small incisions supports enhanced recovery pathways and improved operating room efficiency. Demand is shaped by rising surgical volumes, broader use of ambulatory surgery centers, stricter infection prevention protocols, and increased surgeon preference for reliable specimen retrieval bags, pouches, and containment systems compatible with trocar-based access. Product priorities increasingly include deployment simplicity, tear resistance, specimen visibility, ergonomic handling, compatibility with robotic instruments, and sterile single-use packaging. In this environment, healthcare providers are evaluating specimen retrieval systems not only as procedural accessories but also as safeguards for surgical quality, pathology integrity, and patient safety.

Transformative Shifts in the Specimen Retrieval Systems Landscape

The specimen retrieval systems landscape is being reshaped by the convergence of minimally invasive surgery, robotic platforms, sustainability expectations, and heightened clinical governance. Hospitals and surgical centers are placing stronger emphasis on devices that can be deployed quickly, maintain containment under traction, and support standardized workflows across multiple specialties. Robotic-assisted procedures are influencing design requirements, including improved shaft compatibility, controlled opening mechanisms, and retrieval systems that can be manipulated in confined anatomical spaces. At the same time, infection prevention and contamination control remain central, particularly in procedures involving malignancy, infected tissue, gallbladder extraction, ovarian cyst removal, appendectomy, nephrectomy, and colectomy. Procurement teams are also balancing clinical performance with cost discipline, packaging waste reduction, and supply resilience. Regulatory scrutiny around sterility assurance, biocompatibility, labeling, risk management, and post-market surveillance is encouraging manufacturers and healthcare providers to prioritize validated materials, traceable quality systems, and evidence-supported use protocols.

Cumulative Impact of Artificial Intelligence on Specimen Retrieval Systems

Artificial intelligence is beginning to influence the specimen retrieval systems ecosystem indirectly but meaningfully through surgical planning, operating room analytics, inventory optimization, and quality monitoring. AI-enabled surgical video analysis can help identify procedural steps, assess workflow variation, and support training on safe tissue containment and extraction techniques. Predictive analytics can improve supply chain planning by aligning retrieval system inventory with procedure mix, surgeon preference cards, seasonality, and operating room schedules, reducing both stockouts and excess sterile inventory. In robotic and image-guided surgery, AI-supported decision tools may further standardize port placement, extraction route selection, and specimen handling pathways. Quality and risk teams can also apply AI to adverse event reports, complaint trends, and device utilization data to detect material failures, deployment issues, or training gaps earlier. While AI does not replace clinical judgment, its cumulative impact is expected to strengthen evidence-based procurement, improve operating room efficiency, and enhance consistency in specimen containment practices.

Key Regional Insights Across Global Specimen Retrieval System Adoption

In Asia-Pacific, rising access to minimally invasive surgery, expanding hospital infrastructure, and growing adoption of laparoscopic and robotic-assisted procedures are reinforcing the need for dependable specimen retrieval systems across China, India, Japan, South Korea, Australia, and Southeast Asian healthcare networks. Europe is characterized by stringent medical device regulation, advanced surgical practice, and strong emphasis on clinical evidence, sustainability, and standardized procurement across public and private healthcare systems. North America remains highly procedure-driven, supported by established laparoscopic surgery penetration, ambulatory surgery center utilization, strong infection control standards, and surgeon demand for consistent device performance in high-throughput operating environments. Latin America is progressing through broader private hospital investment, medical training initiatives, and increasing availability of minimally invasive surgical equipment, although procurement variability and reimbursement constraints influence product selection. Africa presents a more heterogeneous landscape, with demand concentrated in urban referral centers and private hospitals where laparoscopic capability is expanding, while broader uptake depends on training, infrastructure, affordability, and reliable distribution. The Middle East is advancing through investment in tertiary hospitals, surgical specialization, and medical tourism hubs, creating demand for premium sterile surgical accessories and robotic-compatible retrieval solutions.

Key Group Insights for Specimen Retrieval Systems

NATO member states include many advanced healthcare systems where surgical readiness, supply continuity, and standardized medical procurement can influence demand for reliable sterile surgical consumables, including specimen retrieval bags and containment devices. G7 countries generally show high clinical adoption of laparoscopic and robotic surgery, robust quality systems, and strong expectations for validated device performance, surgeon usability, and post-market safety data. BRICS economies combine large surgical patient populations with expanding minimally invasive procedure adoption, but purchasing patterns vary by reimbursement maturity, domestic manufacturing policy, and hospital tier. The European Union is shaped by harmonized medical device regulation, sustainability considerations, and evidence-based purchasing, making compliance, documentation, and product traceability important differentiators for specimen retrieval systems. ASEAN healthcare systems are strengthening minimally invasive surgery capacity through public hospital modernization, private healthcare expansion, and regional training programs, supporting wider use of specimen retrieval systems in general surgery, obstetrics and gynecology, and urology. GCC countries are notable for high investment in advanced surgical infrastructure, strong interest in robotic-assisted procedures, and centralized procurement models that favor quality-certified sterile devices.

Key Country Insights in Specimen Retrieval Systems

China is expanding rapidly in minimally invasive and robotic surgery capacity, with domestic production and hospital modernization shaping product availability. The United States demonstrates strong adoption of specimen retrieval systems due to high volumes of laparoscopic, robotic-assisted, outpatient, and specialty surgical procedures, supported by rigorous infection prevention and hospital quality protocols. Japan prioritizes precision, quality, and surgeon ergonomics in advanced laparoscopic and endoscopic surgery, while India is driven by expanding private hospitals, rising laparoscopic procedure volumes, and strong cost sensitivity, making affordability and ease of use critical. Germany, the United Kingdom, France, Italy, and Spain reflect mature European surgical practice, where regulatory compliance, product consistency, and sustainability are important purchasing factors; Germany's engineering-led healthcare ecosystem emphasizes validated performance, the United Kingdom prioritizes standardized procurement across national and private pathways, France's public hospital structure reinforces procurement discipline, Italy maintains broad specialist use in gynecology and general surgery, and Spain continues to integrate minimally invasive workflows across regional health systems. Australia benefits from established minimally invasive surgical standards and hospital procurement frameworks, while South Korea's advanced surgical technology environment supports adoption of high-quality retrieval systems suited to laparoscopic and robotic workflows. Canada shows steady use across publicly funded surgical pathways, with procurement often emphasizing clinical reliability, value, and standardization. Russia maintains demand through major urban surgical centers, though access and procurement dynamics may vary by region. Brazil and Mexico are advancing through private hospital networks, growing laparoscopic training, and increasing demand for cost-effective sterile surgical consumables.

Actionable Recommendations for Specimen Retrieval System Leaders

Industry leaders should prioritize clinically validated specimen retrieval systems that combine deployment reliability, puncture resistance, visibility, and secure closure with compatibility across laparoscopic and robotic-assisted surgical workflows. Manufacturers should invest in surgeon-centered design, specialty-specific configurations, and training resources that reduce technique variability and support consistent containment. Procurement and commercial teams should align product portfolios with high-volume procedures such as cholecystectomy, appendectomy, colectomy, hysterectomy, ovarian cystectomy, nephrectomy, and bariatric surgery while maintaining clear value propositions for ambulatory surgery centers and public hospitals. Quality leaders should strengthen post-market surveillance, complaint analytics, sterility assurance, and material traceability to meet evolving regulatory expectations. Sustainability should be addressed through packaging optimization, responsible material selection, and waste-conscious logistics without compromising sterility or performance. Strategic distributors should build resilient regional supply networks, surgeon education programs, and regulatory readiness to support adoption in emerging minimally invasive surgery markets.

Research Methodology for Specimen Retrieval Systems Analysis

This executive summary is developed using a structured secondary and primary research approach focused on verified healthcare, surgical, regulatory, and clinical practice indicators. The methodology includes review of publicly available regulatory guidance, medical device safety principles, clinical literature on minimally invasive surgery and specimen containment, hospital procurement considerations, surgical workflow trends, and regional healthcare infrastructure developments. Insights are triangulated across procedure adoption patterns, infection prevention requirements, device usability factors, and regulatory expectations without relying on market sizing, market share, or forecasting. Regional, group, and country-level perspectives are interpreted through healthcare access, surgical capability, reimbursement environment, regulatory maturity, and procurement behavior. The analysis emphasizes data-backed industry drivers such as minimally invasive surgery expansion, robotic surgery integration, ambulatory care growth, sterility requirements, and quality management practices while excluding speculative claims and unsupported numerical projections.

Conclusion: Advancing Safe and Efficient Specimen Retrieval

Specimen retrieval systems are becoming increasingly important to safe, efficient, and standardized minimally invasive surgery. As laparoscopic and robotic-assisted procedures expand across developed and emerging healthcare systems, the role of secure containment, controlled extraction, and specimen integrity is gaining greater clinical and operational relevance. Regional adoption is influenced by surgical infrastructure, regulatory maturity, reimbursement models, procurement practices, and training availability, while artificial intelligence is strengthening adjacent capabilities in workflow analytics, inventory planning, and quality monitoring. Industry participants that focus on validated performance, ergonomic design, regulatory compliance, supply resilience, and sustainability will be better positioned to meet the needs of hospitals, ambulatory surgery centers, and specialty surgical teams. The long-term direction of the sector is defined by safer specimen handling, improved operating room efficiency, and broader integration of retrieval systems into evidence-based minimally invasive surgical care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Specimen Retrieval Systems Market, by Product Type

• 7.1. Introduction
• 7.2. Retrieval Bags
  • 7.2.1. Detachable Bags
  • 7.2.2. Non-Detachable Bags
• 7.3. Retrieval Devices
  • 7.3.1. Graspers
  • 7.3.2. Forceps

8. Specimen Retrieval Systems Market, by Material

• 8.1. Introduction
• 8.2. Polyurethane
• 8.3. Polyethylene
• 8.4. Nylon
• 8.5. Silicone
• 8.6. Polymer Composites

9. Specimen Retrieval Systems Market, by Procedure Type

• 9.1. Introduction
• 9.2. Minimally Invasive Surgery
• 9.3. Open Surgery
• 9.4. Hybrid Surgery

10. Specimen Retrieval Systems Market, by Sterility

• 10.1. Introduction
• 10.2. Sterile Systems
• 10.3. Non-Sterile Systems

11. Specimen Retrieval Systems Market, by Patient Type

• 11.1. Introduction
• 11.2. Adult
• 11.3. Pediatric
• 11.4. Geriatric

12. Specimen Retrieval Systems Market, by Technology

• 12.1. Introduction
• 12.2. Conventional Retrieval Systems
• 12.3. Smart Retrieval Systems
  • 12.3.1. Sensor-Based Systems
  • 12.3.2. AI-Assisted Systems
• 12.4. Integrated Visualization Systems
• 12.5. Robotic-Compatible Systems

13. Specimen Retrieval Systems Market, by Application

• 13.1. Introduction
• 13.2. Biopsy Sample Transportation
• 13.3. Blood Bank Retrieval
• 13.4. Microbiology Sample Routing
• 13.5. Pathology Specimen Transfer

14. Specimen Retrieval Systems Market, by End User

• 14.1. Introduction
• 14.2. Diagnostic Centers
• 14.3. Hospitals
  • 14.3.1. Public
  • 14.3.2. Private
• 14.4. Ambulatory Surgical Centers
• 14.5. Academic & Research Institutes

15. Specimen Retrieval Systems Market, by Distribution Channel

• 15.1. Introduction
• 15.2. Offline
• 15.3. Online

16. Specimen Retrieval Systems Market, by Region

• 16.1. Asia-Pacific
• 16.2. Europe
• 16.3. North America
• 16.4. Latin America
• 16.5. Africa
• 16.6. Middle East

17. Specimen Retrieval Systems Market, by Group

• 17.1. NATO
• 17.2. G7
• 17.3. BRICS
• 17.4. European Union
• 17.5. ASEAN
• 17.6. GCC

18. Specimen Retrieval Systems Market, by Country

• 18.1. China
• 18.2. United States
• 18.3. Japan
• 18.4. India
• 18.5. Germany
• 18.6. United Kingdom
• 18.7. Australia
• 18.8. France
• 18.9. South Korea
• 18.10. Italy
• 18.11. Canada
• 18.12. Russia
• 18.13. Brazil
• 18.14. Mexico
• 18.15. Spain

19. Competitive Landscape

• 19.1. Market Share Analysis, 2025
• 19.2. FPNV Positioning Matrix, 2025
• 19.3. Market Concentration Analysis, 2025
  • 19.3.1. Concentration Ratio (CR)
  • 19.3.2. Herfindahl Hirschman Index (HHI)
• 19.4. Recent Developments & Impact Analysis, 2025
• 19.5. Product Portfolio Analysis, 2025
• 19.6. Benchmarking Analysis, 2025

20. Company Profiles

• 20.1. Ackermann Instrumente GmbH
• 20.2. Addler
• 20.3. Applied Medical Resources Corporation
• 20.4. B. Braun Melsungen AG
• 20.5. Boston Scientific Corporation
• 20.6. Changzhou Wick Medical Equipment Co. Ltd
• 20.7. CONMED Corporation
• 20.8. Cook Medical LLC
• 20.9. CooperSurgical Inc
• 20.10. Duomed Group
• 20.11. Espiner Medical
• 20.12. Grena Ltd
• 20.13. Hangzhou Boer Medical Instruments Co. Ltd
• 20.14. Johnson & Johnson Services Inc
• 20.15. Laprosurge
• 20.16. Locamed Ltd
• 20.17. Medtronic plc
• 20.18. Olympus Corporation
• 20.19. Purple Surgical Inc
• 20.20. Richard Wolf GmbH
• 20.21. Shenzhen Mindray Bio-Medical Electronics Co. Ltd
• 20.22. Stryker Corporation
• 20.23. Teleflex Incorporated
• 20.24. Victor Medical Instruments